200
Participants
Start Date
July 31, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
December 31, 2008
DIO-902
150mg tablet once per day for 16 weeks
DIO-902
300mg tablet once per day for 16 weeks
DIO-902
450mg DIO-902 tablet once daily for 16 weeks
DIO-902 placebo
DIO-902 placebo tablet once daily for 16 weeks
DIO-902
150mg tablet of DIO-902 once daily for 16 weeks
DIO-902
300mg DIO-902 tablet daily for 16 weeks
DIO-902
450mg DIO-902 tablet for 16 weeks
DIO-902 placebo
DIO-902 placebo tablet once daily for 16 weeks
Keough Institute, Nedands
School of Medicine and Pharmacology, Fremantle
Dr. Terence Hart, Muscle Shoals
Creighton Diabetes Center, Omaha
Arkansas Primary Care Clinic, Little Rock
Research Solutions, Jonesboro
AHS Oklahoma Physician Group, Tulsa
Diabetes Glandular and Disease Research Associates, San Antonio
Covance CRU, Austin
Genova Research, Tucson
Advanced Medical Research, Lakewood
Mills-Peninsula Helath Services, San Mateo
Diabetes Research Goup University of Hawaii at Manoa, Honolulu
Covance Clinical Research Unit - Dr. Andrew Ahmann, Portland
Flinders Medical Centre, Adelaide
Lyell McEwin Hospital, North Western Adelaide
ECRU, Box Hill, Melbourne
Royal Melbourn Hospital, Victoria
Middlemore Hospital, Otahuhu
Lipid and Diabetes Research, Christchurch
Waikaito Hospital, Hamilton
Diabetes Centre, Wellington
Endocrinology Research Unit, Herston Road
Endocrinology Department, St Leonards
Lead Sponsor
DiObex
INDUSTRY